These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7921327)

  • 1. Early decrease in skin reactivity after rush venom immunotherapy.
    Antonicelli L; Pucci S; Bilò MB; Garritani MS; Bonifazi F
    J Investig Allergol Clin Immunol; 1994; 4(2):57-60. PubMed ID: 7921327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of specific immunotherapy using a four-hour ultra-rush induction scheme in bee and wasp allergy.
    Roll A; Hofbauer G; Ballmer-Weber BK; Schmid-Grendelmeier P
    J Investig Allergol Clin Immunol; 2006; 16(2):79-85. PubMed ID: 16689180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rush hymenoptera venom immunotherapy is efficacious and safe.
    Pasaoglu G; Sin BA; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(4):232-8. PubMed ID: 16889280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of safety, risk factors and pretreatment methods during rush hymenoptera venom immunotherapy.
    Gorska L; Chelminska M; Kuziemski K; Skrzypski M; Niedoszytko M; Damps-Konstanska I; Szymanowska A; Siemińska A; Wajda B; Drozdowska A; Jutel M; Jassem E
    Int Arch Allergy Immunol; 2008; 147(3):241-5. PubMed ID: 18594155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W; Chyrek-Borowska S
    Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A; Bonneau JC; Drouet M; Le Sellin J
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-assisted quantification of in vitro activated basophils in the diagnosis of wasp venom allergy and follow-up of wasp venom immunotherapy.
    Ebo DG; Hagendorens MM; Schuerwegh AJ; Beirens LM; Bridts CH; De Clerck LS; Stevens WJ
    Cytometry B Clin Cytom; 2007 May; 72(3):196-203. PubMed ID: 17111386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ant venoms: a rare cause of allergic reactions in Switzerland].
    Seebach JD; Bucher C; Anliker M; Schmid-Grendelmeier P; Wüthrich B
    Schweiz Med Wochenschr; 2000 Nov; 130(47):1805-13. PubMed ID: 11130146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of hyposensitization with bee and wasp venom].
    Adolph J; Dehnert I; Fischer JF; Wenz W
    Z Erkr Atmungsorgane; 1986; 166(1):119-24. PubMed ID: 3953108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of venom immunotherapy (VIT) based on conventional techniques and monitoring of immunoglobulin E to individual venom allergens.
    Carballada F; Boquete M; Núñez R; Lombardero M; de la Torre F
    J Investig Allergol Clin Immunol; 2010; 20(6):506-13. PubMed ID: 21243935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific ultrarush desensitization in Hymenoptera venom-allergic patients.
    Schiavino D; Nucera E; Pollastrini E; De Pasquale T; Buonomo A; Bartolozzi F; Lombardo C; Roncallo C; Patriarca G
    Ann Allergy Asthma Immunol; 2004 Apr; 92(4):409-13. PubMed ID: 15104191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD28 expression is increased in venom allergic patients but is not modified by specific immunotherapy.
    Tsicopoulos A; Labalette M; Akoum H; Duez C; Wallaert B; Dessaint JP; Tonnel AB
    Clin Exp Allergy; 1996 Oct; 26(10):1119-24. PubMed ID: 8911696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The basophil activation test in wasp venom allergy: sensitivity, specificity and monitoring specific immunotherapy.
    Erdmann SM; Sachs B; Kwiecien R; Moll-Slodowy S; Sauer I; Merk HF
    Allergy; 2004 Oct; 59(10):1102-9. PubMed ID: 15355470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy].
    Steiss JO; Hüls G; Gortner L; Lindemann H
    Klin Padiatr; 2004; 216(2):79-82. PubMed ID: 15106079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Allergic reactions to insect bites].
    Urbanek R
    Ther Umsch; 1989 Sep; 46(9):654-62. PubMed ID: 2678576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basophil degranulation test (BDT) as a parameter of hyposensitization with Hymenoptera venoms].
    Dietschi R; Wüthrich B; Marti-Wyss S; Cuhat J
    Schweiz Med Wochenschr; 1987 Oct; 117(44):1728-35. PubMed ID: 3685930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy with wasp venom is accompanied by wide-ranging immune responses that need further exploration.
    Brasch J; Maidusch T
    Acta Derm Venereol; 2009; 89(5):466-9. PubMed ID: 19734970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.